Medicare Enrolled

Dr. Virginia Porras, P.A.-C

Family Medicine - Adult · Dallas, TX
Low-engagement
700 N PEARL ST STE N208, Dallas, TX 75201
2149999355
In practice since 2007 (19 years)
NPI: 1669594834 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Porras from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Porras? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Porras

Dr. Virginia Porras is a family medicine - adult specialist in Dallas, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Porras received a total of $6,755 from 32 pharmaceutical and/or device companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine - adult. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Porras is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $6,755 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,755
Total received (2021-2024)
Avg $1,689/year across 4 years
Top 8% in TX for family medicine - adult
32
Companies
368
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,755 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,208
2023
$1,765
2022
$1,310
2021
$1,473

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$1,020
AstraZeneca Pharmaceuticals LP
$1,007
GlaxoSmithKline, LLC.
$757
Novo Nordisk Inc
$701
Boehringer Ingelheim Pharmaceuticals, Inc.
$385
ABBVIE INC.
$352
Abbott Laboratories
$340
Amarin Pharma Inc.
$290
ViiV Healthcare Company
$280
PFIZER INC.
$256
Amgen Inc.
$255
Currax Pharmaceuticals LLC
$158
IDORSIA PHARMACEUTICALS US INC
$131
SHIELD THERAPEUTICS INC
$124
Intuitive Surgical, Inc.
$100
Alnylam Pharmaceuticals Inc.
$96
Janssen Pharmaceuticals, Inc
$75
Exact Sciences Corporation
$54
Biohaven Pharmaceutical Holding Company Ltd.
$54
Shield Therapeutics Inc
$40
Eisai Inc.
$38
CLOZEX MEDICAL INC
$38
Teva Pharmaceuticals USA, Inc.
$33
Antares Pharma, Inc.
$30
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$30
Merck Sharp & Dohme Corporation
$24
Dexcom, Inc.
$23
AbbVie Inc.
$18
Biohaven Pharmaceuticals, Inc.
$17
Mylan Specialty L.P.
$15
Novartis Pharmaceuticals Corporation
$14
Genentech USA, Inc.
$2
Top 3 companies account for 41.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · AIMOVIG · AIRSUPRA · APRETUDE · AREXVY · AirDuo Digihaler · BREZTRI · COMIRNATY · CONTRAVE · Clozex Skin Closure Device · Cologuard Collection Kit · Da Vinci Surgical System · Dayvigo · Dexcom G6 Transmitter · EMGALITY · Ellipse ICD · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fortify Assura · FreeStyle Libre 2 · JANUVIA · JARDIANCE · MOUNJARO · NURTEC ODT · ONPATTRO · Otezla · Ozempic · PAXLOVID · QULIPTA · QUVIVIQ · RYBELSUS · Rybelsus · SHINGRIX · SPRAVATO · Saxenda · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · Vascepa · Wegovy · XIFAXAN · XYOSTED · Xofluza · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine - adult in TX.

Looking for a family medicine - adult specialist in Dallas?
Compare family medicine - adults in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse family medicine - adults nearby

Geographic Context

Family medicine - adults within 10 mi
39
Per 100K population
1.5
County median income
$74,149
Nearest hospital
BAYLOR SCOTT AND WHITE MEDICAL CENTER UPTOWN
1.1 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Porras is a family medicine - adult specialist, with low-engagement industry engagement in the top 8% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Porras receive payments from pharmaceutical companies?
Yes. Dr. Porras received a total of $6,755 from 32 companies across 368 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Porras) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Medicine - Adults in Dallas
Browse family medicine - adults in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine - Adults in TX
Family medicine - adults ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine - Adults in TX
Which TX family medicine - adults receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →